Published in N Engl J Med on November 12, 2009
Stenting and medical therapy for atherosclerotic renal-artery stenosis. N Engl J Med (2013) 8.91
Predialysis nephrology care of older patients approaching end-stage renal disease. Arch Intern Med (2011) 5.11
Measuring low-value care in Medicare. JAMA Intern Med (2014) 3.39
Changes in Low-Value Services in Year 1 of the Medicare Pioneer Accountable Care Organization Program. JAMA Intern Med (2015) 3.01
2011 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Peripheral Artery Disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2011) 2.71
Roll-in experience from the Cardiovascular Outcomes with Renal Atherosclerotic Lesions (CORAL) study. J Vasc Interv Radiol (2013) 1.52
Adipose tissue-derived mesenchymal stem cells improve revascularization outcomes to restore renal function in swine atherosclerotic renal artery stenosis. Stem Cells (2012) 1.44
Autologous Mesenchymal Stem Cells Increase Cortical Perfusion in Renovascular Disease. J Am Soc Nephrol (2017) 1.41
Renal Artery Stent Outcomes: Effect of Baseline Blood Pressure, Stenosis Severity, and Translesion Pressure Gradient. J Am Coll Cardiol (2015) 1.40
Persistent kidney dysfunction in swine renal artery stenosis correlates with outer cortical microvascular remodeling. Am J Physiol Renal Physiol (2011) 1.35
Blood oxygen level-dependent magnetic resonance imaging identifies cortical hypoxia in severe renovascular disease. Hypertension (2011) 1.19
Renovascular hypertension and ischemic nephropathy. Am J Hypertens (2010) 1.18
Renovascular hypertension: screening and modern management. Eur Heart J (2011) 1.13
Screening for significant atherosclerotic renal artery stenosis with a regression model in patients undergoing transradial coronary angiography/intervention. J Zhejiang Univ Sci B (2012) 1.13
Percutaneous revascularization for ischemic nephropathy: the past, present, and future. Kidney Int (2012) 1.12
Mesenchymal stem cells improve medullary inflammation and fibrosis after revascularization of swine atherosclerotic renal artery stenosis. PLoS One (2013) 1.12
Stent revascularization restores cortical blood flow and reverses tissue hypoxia in atherosclerotic renal artery stenosis but fails to reverse inflammatory pathways or glomerular filtration rate. Circ Cardiovasc Interv (2013) 1.09
Atherosclerotic renal artery stenosis--diagnosis and treatment. Mayo Clin Proc (2011) 1.08
Renal arteries: isotropic, high-spatial-resolution, unenhanced MR angiography with three-dimensional radial phase contrast. Radiology (2010) 1.08
Early atherosclerosis aggravates the effect of renal artery stenosis on the swine kidney. Am J Physiol Renal Physiol (2010) 1.08
Genetic deficiency of Smad3 protects the kidneys from atrophy and interstitial fibrosis in 2K1C hypertension. Am J Physiol Renal Physiol (2012) 1.05
Lipid, blood pressure and kidney update 2013. Int Urol Nephrol (2014) 1.05
Endothelial outgrowth cells shift macrophage phenotype and improve kidney viability in swine renal artery stenosis. Arterioscler Thromb Vasc Biol (2013) 1.04
TGF expression and macrophage accumulation in atherosclerotic renal artery stenosis. Clin J Am Soc Nephrol (2012) 1.04
Optimal management of renal artery fibromuscular dysplasia. Ther Clin Risk Manag (2014) 1.03
Changes in glomerular filtration rate after renal revascularization correlate with microvascular hemodynamics and inflammation in Swine renal artery stenosis. Circ Cardiovasc Interv (2012) 1.02
Clinical practice. Renal-artery stenosis. N Engl J Med (2009) 0.99
Management of hypertension in the elderly. Nat Rev Cardiol (2012) 0.98
Systemic arterial and venous determinants of renal hemodynamics in congestive heart failure. Heart Fail Rev (2012) 0.98
Blood oxygen level-dependent (BOLD) MRI in renovascular hypertension. Curr Hypertens Rep (2011) 0.97
Prevalence and prognostic significance of renal artery calcification in patients with diabetes and proteinuria. Clin J Am Soc Nephrol (2010) 0.97
Hypertension in chronic kidney disease: navigating the evidence. Int J Hypertens (2011) 0.95
Management of atherosclerotic renovascular disease after Cardiovascular Outcomes in Renal Atherosclerotic Lesions (CORAL). Nephrol Dial Transplant (2014) 0.95
How current are leading evidence-based medical textbooks? An analytic survey of four online textbooks. J Med Internet Res (2012) 0.93
Role of the kidneys in resistant hypertension. Int J Hypertens (2011) 0.93
Is there any reason to stent atherosclerotic renal artery stenosis? Am J Kidney Dis (2010) 0.93
Low risk for nephrogenic systemic fibrosis in nondialysis patients who have chronic kidney disease and are investigated with gadolinium-enhanced magnetic resonance imaging. Clin J Am Soc Nephrol (2010) 0.93
Renal artery stenosis-when to screen, what to stent? Curr Atheroscler Rep (2014) 0.92
Atherosclerotic disease of the abdominal aorta and its branches: prognostic implications in patients with heart failure. Heart Fail Rev (2012) 0.90
Common secondary causes of resistant hypertension and rational for treatment. Int J Hypertens (2011) 0.89
Current opinions in renovascular hypertension. Proc (Bayl Univ Med Cent) (2010) 0.88
Redox signaling is an early event in the pathogenesis of renovascular hypertension. Int J Mol Sci (2013) 0.88
Renal resistive index as a marker of vascular damage in cardiovascular diseases. Int Urol Nephrol (2014) 0.86
Renal artery stenosis: epidemiology and treatment. Int J Nephrol Renovasc Dis (2014) 0.85
Predictive role of renal resistive index for clinical outcome after revascularization in hypertensive patients with atherosclerotic renal artery stenosis: a monocentric observational study. Cardiovasc Ultrasound (2014) 0.84
Management of patients with resistant hypertension: current treatment options. Integr Blood Press Control (2013) 0.84
Darkness at the end of the tunnel: poststenotic kidney injury. Physiology (Bethesda) (2013) 0.83
Renal autoregulation in medical therapy of renovascular hypertension. Arch Med Sci (2010) 0.83
Management of hypertension in CKD: beyond the guidelines. Adv Chronic Kidney Dis (2015) 0.83
Hypertension-attributed nephropathy: what's in a name? Nat Rev Nephrol (2015) 0.82
Attenuation of hypertension and renal damage in renovascular hypertensive rats by iron restriction. Hypertens Res (2016) 0.82
Concise review: mesenchymal stem cell treatment for ischemic kidney disease. Stem Cells (2013) 0.82
Surveying the medical literature: five notable articles in general internal medicine from 2008 and 2009. Open Med (2010) 0.82
Medical reversal: why we must raise the bar before adopting new technologies. Yale J Biol Med (2011) 0.82
Statins and renovascular disease in the elderly: a population-based cohort study. Eur Heart J (2010) 0.82
Cardiovascular magnetic resonance in systemic hypertension. J Cardiovasc Magn Reson (2012) 0.82
Blood oxygen level-dependent (BOLD) MRI analysis in atherosclerotic renal artery stenosis. Curr Opin Nephrol Hypertens (2013) 0.82
Extrarenal atherosclerotic disease blunts renal recovery in patients with renovascular hypertension. J Hypertens (2014) 0.82
Contrast-induced acute kidney injury: short- and long-term implications. Semin Nephrol (2011) 0.82
Radionuclides in nephrourology, Part 2: pitfalls and diagnostic applications. J Nucl Med (2014) 0.81
Endothelin-a receptor antagonism after renal angioplasty enhances renal recovery in renovascular disease. J Am Soc Nephrol (2014) 0.81
Endovascular intervention in renovascular disease: a pictorial review. Insights Imaging (2014) 0.81
Metabolomics of renal venous plasma from individuals with unilateral renal artery stenosis and essential hypertension. J Hypertens (2015) 0.81
The rise and fall of renal artery angioplasty and stenting in the United States, 1988-2009. J Vasc Surg (2013) 0.81
Update on intervention versus medical therapy for atherosclerotic renal artery stenosis. J Vasc Surg (2015) 0.80
Non-contrast-enhanced MRA of renal artery stenosis: validation against DSA in a porcine model. Eur Radiol (2015) 0.80
Diagnosis and treatment of renal artery stenosis. Nat Rev Nephrol (2010) 0.80
Endovascular renal denervation: a novel sympatholytic with relevance to chronic kidney disease. Clin Kidney J (2013) 0.80
Diagnostic criteria for renovascular disease: where are we now? Nephrol Dial Transplant (2012) 0.80
Use of renin-angiotensin inhibitors in people with renal artery stenosis. Clin J Am Soc Nephrol (2014) 0.80
Recognition and Management of Resistant Hypertension. Clin J Am Soc Nephrol (2016) 0.80
Differences in GFR and Tissue Oxygenation, and Interactions between Stenotic and Contralateral Kidneys in Unilateral Atherosclerotic Renovascular Disease. Clin J Am Soc Nephrol (2016) 0.79
Assessment of the kidneys: magnetic resonance angiography, perfusion and diffusion. J Cardiovasc Magn Reson (2011) 0.79
Chronic renal ischemia in humans: can cell therapy repair the kidney in occlusive renovascular disease? Physiology (Bethesda) (2015) 0.79
Diagnosis and therapy of atheromatous renal artery stenosis. Clin Exp Nephrol (2013) 0.79
Atherosclerotic renal artery stenosis. Ann Transl Med (2017) 0.78
Relationship of Albuminuria and Renal Artery Stent Outcomes: Results From the CORAL Randomized Clinical Trial (Cardiovascular Outcomes With Renal Artery Lesions). Hypertension (2016) 0.78
Hypertension Treatment for Patients with Advanced Chronic Kidney Disease. Curr Cardiovasc Risk Rep (2014) 0.78
Effects of Stenting for Atherosclerotic Renal Artery Stenosis on eGFR and Predictors of Clinical Events in the CORAL Trial. Clin J Am Soc Nephrol (2016) 0.78
The association between renal atherosclerotic plaque characteristics and renal function before and after renal artery intervention. Mayo Clin Proc (2011) 0.78
Image-guided urological interventions: What the urologists must know. Indian J Urol (2015) 0.78
Risk factors associated with end-stage renal disease (ESRD) in patients with atherosclerotic renal artery stenosis: a nationwide population-based analysis. Medicine (Baltimore) (2015) 0.78
The need for randomized trials to prove the safety and efficacy of parachutes, bulletproof vests, and percutaneous renal intervention. Mayo Clin Proc (2011) 0.78
Determination of Single-Kidney Glomerular Filtration Rate in Human Subjects by Using CT. Radiology (2015) 0.77
A prediction model for renal artery stenosis using carotid ultrasonography measurements in patients undergoing coronary angiography. BMC Nephrol (2014) 0.77
Transradial access for renal artery intervention. Interv Med Appl Sci (2014) 0.77
Frequency and predictors of renal artery stenosis in patients undergoing simultaneous coronary and renal catheterization. J Tehran Heart Cent (2012) 0.77
Pickering syndrome: high-risk stenting of a renal artery stenosis in a multimorbid patient presenting with progressive congestive heart failure. Clin Res Cardiol (2013) 0.76
relationship between distribution of coronary artery lesions and renal artery stenosis in patients undergoing simultaneous coronary and renal angiography. Clin Med Insights Cardiol (2011) 0.76
The association between atherosclerotic renal artery stenosis and acute kidney injury in patients undergoing cardiac surgery. PLoS One (2013) 0.76
Efficacy of percutaneous transluminal renal angioplasty with stent in elderly male patients with atherosclerotic renal artery stenosis. Clin Interv Aging (2012) 0.76
Atherosclerotic renal artery stenosis: current status. Adv Chronic Kidney Dis (2015) 0.76
Response of blood pressure after percutaneous transluminal renal artery angioplasty and stenting. World J Cardiol (2013) 0.76
Renal artery stenosis: a classic presentation, a rare cause... BMJ Case Rep (2012) 0.76
CXCL16 regulates renal injury and fibrosis in experimental renal artery stenosis. Am J Physiol Heart Circ Physiol (2016) 0.76
Does Renal Artery Stenting Prevent Clinical Events? Clin J Am Soc Nephrol (2016) 0.76
Concomitant coronary and renal revascularization improves left ventricular hypertrophy more than coronary stenting alone in patients with ischemic heart and renal disease. J Zhejiang Univ Sci B (2016) 0.76
Changes in inflammatory biomarkers after renal revascularization in atherosclerotic renal artery stenosis. Nephrol Dial Transplant (2016) 0.76
Clinical effectiveness of secondary interventions for restenosis after renal artery stenting. J Vasc Surg (2013) 0.75
Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet (2009) 13.64
A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21. Nat Genet (2007) 11.62
Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov Disord (2010) 9.34
Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study. Lancet (2007) 9.23
A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3. Nat Genet (2008) 6.26
Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data. Lancet (2014) 6.23
Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 randomized trials. J Clin Oncol (2005) 6.20
Aspirin in patients undergoing noncardiac surgery. N Engl J Med (2014) 6.10
A genome-wide association study shows that common alleles of SMAD7 influence colorectal cancer risk. Nat Genet (2007) 6.02
Donepezil and memantine for moderate-to-severe Alzheimer's disease. N Engl J Med (2012) 5.64
Addition of gemtuzumab ozogamicin to induction chemotherapy improves survival in older patients with acute myeloid leukemia. J Clin Oncol (2012) 5.52
Uterine-artery embolization versus surgery for symptomatic uterine fibroids. N Engl J Med (2007) 4.61
Low-dose aspirin for the prevention of atherothrombosis. N Engl J Med (2005) 4.57
Identification of patients with acute myeloblastic leukemia who benefit from the addition of gemtuzumab ozogamicin: results of the MRC AML15 trial. J Clin Oncol (2010) 4.12
Alemtuzumab-based induction treatment versus basiliximab-based induction treatment in kidney transplantation (the 3C Study): a randomised trial. Lancet (2014) 4.05
Common genetic variants at the CRAC1 (HMPS) locus on chromosome 15q13.3 influence colorectal cancer risk. Nat Genet (2007) 3.93
Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia. N Engl J Med (2005) 3.92
Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials. Lancet (2015) 3.79
Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study. Lancet (2005) 3.75
Value of mismatch repair, KRAS, and BRAF mutations in predicting recurrence and benefits from chemotherapy in colorectal cancer. J Clin Oncol (2011) 3.67
Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): a randomised, open-label trial. Lancet Neurol (2010) 3.56
Analyses of cancer data from three ezetimibe trials. N Engl J Med (2008) 3.44
Curability of patients with acute myeloid leukemia who did not undergo transplantation in first remission. J Clin Oncol (2013) 2.74
Serum phosphorus levels associate with coronary atherosclerosis in young adults. J Am Soc Nephrol (2008) 2.65
Warfarin thromboprophylaxis in cancer patients with central venous catheters (WARP): an open-label randomised trial. Lancet (2009) 2.59
MPL mutations in myeloproliferative disorders: analysis of the PT-1 cohort. Blood (2008) 2.55
Levonorgestrel intrauterine system versus medical therapy for menorrhagia. N Engl J Med (2013) 2.50
Randomized clinical trials--removing unnecessary obstacles. N Engl J Med (2013) 2.43
Reticulin accumulation in essential thrombocythemia: prognostic significance and relationship to therapy. J Clin Oncol (2009) 2.43
End points for colon cancer adjuvant trials: observations and recommendations based on individual patient data from 20,898 patients enrolled onto 18 randomized trials from the ACCENT Group. J Clin Oncol (2007) 2.41
New oral anticoagulants in atrial fibrillation and acute coronary syndromes: ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease position paper. J Am Coll Cardiol (2012) 2.41
Calcium-phosphate levels and cardiovascular disease in community-dwelling adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J (2008) 2.35
Prospective minimal residual disease monitoring to predict relapse of acute promyelocytic leukemia and to direct pre-emptive arsenic trioxide therapy. J Clin Oncol (2009) 2.26
The unrecognized prevalence of chronic kidney disease in diabetes. Nephrol Dial Transplant (2005) 2.24
Renovascular hypertension in children. Lancet (2008) 2.17
Physical health and mental illness: a silent scandal. Int J Ment Health Nurs (2012) 2.10
Excessive daytime sleepiness and driving: regulations for road safety. Clin Med (2004) 2.09
Does adjuvant interferon-alpha for high-risk melanoma provide a worthwhile benefit? A meta-analysis of the randomised trials. Cancer Treat Rev (2003) 2.08
Recommended standards for reports dealing with arteriovenous hemodialysis accesses. J Vasc Surg (2002) 2.07
The impact of dose escalation and resistance modulation in older patients with acute myeloid leukaemia and high risk myelodysplastic syndrome: the results of the LRF AML14 trial. Br J Haematol (2009) 1.96
Clinical interventions for treatment non-adherence in psychosis: meta-analysis. Br J Psychiatry (2003) 1.94
Lack of effect of lowering LDL cholesterol on cancer: meta-analysis of individual data from 175,000 people in 27 randomised trials of statin therapy. PLoS One (2012) 1.93
PEPtalk: postexposure prophylaxis against varicella in children with cancer. Arch Dis Child (2011) 1.91
Active dendrites, potassium channels and synaptic plasticity. Philos Trans R Soc Lond B Biol Sci (2003) 1.90
Cholesterol and the risk of renal dysfunction in apparently healthy men. J Am Soc Nephrol (2003) 1.87
RAS mutation in acute myeloid leukemia is associated with distinct cytogenetic subgroups but does not influence outcome in patients younger than 60 years. Blood (2005) 1.85
High rates of clustering of strains causing tuberculosis in Harare, Zimbabwe: a molecular epidemiological study. J Clin Microbiol (2004) 1.84
Search for low penetrance alleles for colorectal cancer through a scan of 1467 non-synonymous SNPs in 2575 cases and 2707 controls with validation by kin-cohort analysis of 14 704 first-degree relatives. Hum Mol Genet (2006) 1.84
Serious mental illness and physical health problems: a discussion paper. Int J Nurs Stud (2006) 1.83
Physiotherapy versus placebo or no intervention in Parkinson's disease. Cochrane Database Syst Rev (2012) 1.80
Commentary: Mendelian randomization--an update on its use to evaluate allogeneic stem cell transplantation in leukaemia. Int J Epidemiol (2004) 1.79
Chemotherapy compared with biochemotherapy for the treatment of metastatic melanoma: a meta-analysis of 18 trials involving 2,621 patients. J Clin Oncol (2007) 1.79
Continuous versus interrupted perineal repair with standard or rapidly absorbed sutures after spontaneous vaginal birth: a randomised controlled trial. Lancet (2002) 1.78
Factors predisposing women to chronic pelvic pain: systematic review. BMJ (2006) 1.77
Recognition and management of abdominal compartment syndrome in the United Kingdom. Intensive Care Med (2006) 1.76
Inflammation, endothelial dysfunction, and platelet activation in patients with chronic kidney disease: the chronic renal impairment in Birmingham (CRIB) study. Am J Kidney Dis (2004) 1.76
Antiplatelet drugs: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 1.74
Anticoagulants in heart disease: current status and perspectives. Eur Heart J (2007) 1.73
Cytogenetics of childhood acute myeloid leukemia: United Kingdom Medical Research Council Treatment trials AML 10 and 12. J Clin Oncol (2010) 1.70
Relationship between FLT3 mutation status, biologic characteristics, and response to targeted therapy in acute promyelocytic leukemia. Blood (2005) 1.70
A prospective study of the determinants of renal functional outcome and mortality in atherosclerotic renovascular disease. Am J Kidney Dis (2002) 1.65
Prediction of ESRD and death among people with CKD: the Chronic Renal Impairment in Birmingham (CRIB) prospective cohort study. Am J Kidney Dis (2010) 1.65
An RCT of adherence therapy for people with schizophrenia in Chiang Mai, Thailand. J Clin Nurs (2007) 1.62
District nurses' involvement and attitudes to mental health problems: a three-area cross-sectional study. J Clin Nurs (2005) 1.61
Body mass index has no effect on rate of progression of chronic kidney disease in non-diabetic subjects. Nephrol Dial Transplant (2012) 1.59
Opportunistic screening for genital Chlamydia trachomatis infection and partner follow-up in family planning clinics in three Scottish cities. J Fam Plann Reprod Health Care (2004) 1.58
Current status of prosthetic bypass grafts: a review. J Biomed Mater Res B Appl Biomater (2005) 1.56
Sudden cardiac death in hemodialysis patients: an in-depth review. Am J Kidney Dis (2011) 1.56
PLUTO trial protocol: percutaneous shunting for lower urinary tract obstruction randomised controlled trial. BJOG (2007) 1.55
Laparoscopic uterosacral nerve ablation for alleviating chronic pelvic pain: a randomized controlled trial. JAMA (2009) 1.53
Optimization of chemotherapy for younger patients with acute myeloid leukemia: results of the medical research council AML15 trial. J Clin Oncol (2013) 1.52
Attempts to optimize induction and consolidation treatment in acute myeloid leukemia: results of the MRC AML12 trial. J Clin Oncol (2009) 1.52
Upper limb deep vein thrombosis: a literature review to streamline the protocol for management. Acta Haematol (2007) 1.51
Bone marrow pathology in essential thrombocythemia: interobserver reliability and utility for identifying disease subtypes. Blood (2007) 1.51
Del (9q) AML: clinical and cytological characteristics and prognostic implications. Br J Haematol (2005) 1.50
Atherosclerotic renovascular disease in chronic heart failure: should we intervene? Eur Heart J (2005) 1.48
Aspirin in Alzheimer's disease: increased risk of intracerebral hemorrhage: cause for concern? Stroke (2010) 1.47
A national survey of GP and nurse attitudes and beliefs towards depression after myocardial infarction. J Clin Nurs (2011) 1.47
Prediction and assessment of responses to renal artery revascularization with dynamic contrast-enhanced magnetic resonance imaging: a pilot study. Am J Physiol Renal Physiol (2013) 1.46
Use of a first-line urine protein-to-creatinine ratio strip test on random urines to rule out proteinuria in patients with chronic kidney disease. Nephrol Dial Transplant (2008) 1.45
Results of a randomized trial in children with Acute Myeloid Leukaemia: medical research council AML12 trial. Br J Haematol (2011) 1.44
Vascular surgery by numbers. Ann R Coll Surg Engl (2007) 1.43
Meta-analysis of outcomes of endovascular treatment of infrapopliteal occlusive disease with drug-eluting stents. J Endovasc Ther (2013) 1.43
The clinical significance of hyperkalaemia-associated repolarization abnormalities in end-stage renal disease. Nephrol Dial Transplant (2012) 1.42
The natural history and clinical significance of intermittent viraemia in patients with initial viral suppression to < 400 copies/ml. AIDS (2002) 1.41
Refinement of the basis and impact of common 11q23.1 variation to the risk of developing colorectal cancer. Hum Mol Genet (2008) 1.40
The value of allogeneic bone marrow transplant in patients with acute myeloid leukaemia at differing risk of relapse: results of the UK MRC AML 10 trial. Br J Haematol (2002) 1.40